Cargando…
Targeted Cytokine Delivery for Cancer Treatment: Engineering and Biological Effects
Anti-tumor properties of several cytokines have already been investigated in multiple experiments and clinical trials. However, those studies evidenced substantial toxicities, even at low cytokine doses, and the lack of tumor specificity. These factors significantly limit clinical applications. Due...
Autores principales: | Rybchenko, Vladislav S., Aliev, Teimur K., Panina, Anna A., Kirpichnikov, Mikhail P., Dolgikh, Dmitry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960319/ https://www.ncbi.nlm.nih.gov/pubmed/36839658 http://dx.doi.org/10.3390/pharmaceutics15020336 |
Ejemplares similares
-
Bispecific Antibodies for IFN-β Delivery to ErbB2(+) Tumors
por: Rybchenko, Vladislav S., et al.
Publicado: (2021) -
Recombinant Bispecific Antibodies to the Human ErbB2 Receptor and Interferon-Beta
por: Panina, A. A., et al.
Publicado: (2020) -
Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells
por: Yagolovich, Anne, et al.
Publicado: (2021) -
Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
por: Toporova, V. A., et al.
Publicado: (2023) -
Influence of media composition on recombinant monoclonal IgA1 glycosylation analysed by lectin-based protein microarray and MALDI-MS
por: Pažitná, Lucia, et al.
Publicado: (2020)